268 related articles for article (PubMed ID: 21691880)
21. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
23. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
24. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
25. Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.
Bushati M; Pucciarelli S; Gennaro N; Maretto I; Toppan P; Perin A; Urso EDL; Bagatella A; Spolverato G
Int J Colorectal Dis; 2019 Dec; 34(12):2129-2136. PubMed ID: 31724079
[TBL] [Abstract][Full Text] [Related]
26. Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.
Sung SY; Jang HS; Kim SH; Jeong JU; Jeong S; Song JH; Chung MJ; Cho HM; Kim HJ; Kim JG; Lee IK; Lee JH
Ann Surg; 2019 Jan; 269(1):108-113. PubMed ID: 28742692
[TBL] [Abstract][Full Text] [Related]
27. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
[TBL] [Abstract][Full Text] [Related]
28. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
29. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
31. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
Wasmuth HH; Rekstad LC; Tranø G
Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
[TBL] [Abstract][Full Text] [Related]
32. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
33. Ten-year survival after pathologic complete response in rectal adenocarcinoma.
Sell NM; Qwaider YZ; Goldstone RN; Cauley CE; Cusack JC; Ricciardi R; Bordeianou LG; Berger DL; Kunitake H
J Surg Oncol; 2021 Jan; 123(1):293-298. PubMed ID: 33022797
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
[TBL] [Abstract][Full Text] [Related]
35. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
36. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
37. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years.
Wang L; Li YH; Cai Y; Zhan TC; Gu J
Clin Colorectal Cancer; 2016 Jun; 15(2):152-7. PubMed ID: 26508595
[TBL] [Abstract][Full Text] [Related]
38. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
39. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
[TBL] [Abstract][Full Text] [Related]
40. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
